press releases rule

Archives: Search / 2013 / 2012 / 2011 / 2010 / 2009 / 2008

May 15, 2013
Synthetic Biologics Reports First Quarter 2013 Financial Results
Apr 19, 2013
Synthetic Biologics Reiterates that the Infectious Disease Collaboration with Intrexon Remains in Effect
Apr 16, 2013
Synthetic Biologics Reports Year End 2012 Financial Results
-- Strengthening Infectious Disease Portfolio to Include C. difficile, Pertussis and Acinetobacter Targets --
Apr 4, 2013
Synthetic Biologics Announces Issuance of U.S. Patent Covering Combination of Estriol and Copaxone® for Multiple Sclerosis
-- Patent Expands Company's Patent Portfolio to Include Combination with Number One Selling Multiple Sclerosis Drug --
Mar 12, 2013
Synthetic Biologics to Present at the 25th Annual ROTH Conference
 

Print Email RSS